Joshua Russo's Avatar

Joshua Russo

@jrpcfer

Prostate cancer researcher at Beth Israel Deaconess Medical Center/Instructor at Harvard Medical School.

86
Followers
112
Following
2
Posts
16.01.2025
Joined
Posts Following

Latest posts by Joshua Russo @jrpcfer

Where does TrumpElon think innovation for all their favorite biotech corporations comes from? PCR only exists because somebody was looking for bacteria in hot springs at Yellowstone. Iโ€™m just a private practice ophthalmologist who barely understands p values but even I know this shit is important.

13.03.2025 14:12 ๐Ÿ‘ 601 ๐Ÿ” 140 ๐Ÿ’ฌ 16 ๐Ÿ“Œ 0
Post image Post image

Maybe the crisis in seabirds with multi-organ failure from exposure to plastics will help raise awareness of their serious hazard and lead to action
science.org/doi/10.1126/...

12.03.2025 20:52 ๐Ÿ‘ 369 ๐Ÿ” 102 ๐Ÿ’ฌ 18 ๐Ÿ“Œ 8
Post image Post image

About $74 million in US govt funding (including NIH) went into developing enzalutamide - a multibillion dollar drug that prolonged life for countless men with prostate cancer. Why would anyone cut this support? We need more, not less! @ascocancer.bsky.social @theaacr.bsky.social

23.02.2025 19:11 ๐Ÿ‘ 11 ๐Ÿ” 6 ๐Ÿ’ฌ 1 ๐Ÿ“Œ 0

Also, this is 1st post on the new platform.

Already see alot of familiar faces. Hope the #prostate #cancer #research community continues to grow. ๐Ÿคž

19.01.2025 13:56 ๐Ÿ‘ 1 ๐Ÿ” 0 ๐Ÿ’ฌ 1 ๐Ÿ“Œ 0
Preview
Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancer - PubMed Androgen receptor (AR) splice variants, of which ARv7 is the most common, are increased in castration-resistant prostate cancer, but the extent to which they drive AR activity is unclear. We generated...

Happy to finally have this work out. Enza-resistance in PCa via upregulation of ARv7 and increased chromatin accessibility.

Congrats to lead author (and newly minted PCF YI) Larysa Poluben! She put a tremendous amount of work into this and deserves all the ๐Ÿ‘๐Ÿ‘๐Ÿ‘.

pubmed.ncbi.nlm.nih.gov/39709604/

19.01.2025 13:56 ๐Ÿ‘ 4 ๐Ÿ” 1 ๐Ÿ’ฌ 2 ๐Ÿ“Œ 0